Galnon TFA

CAS No. 1217448-19-5

Galnon TFA( —— )

Catalog No. M37581 CAS No. 1217448-19-5

Galnon is a novel non-peptide galanin receptor agonist (GAL1 and GAL2 with Ki of 11.7 and 34.1 μM respectively).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 79 In Stock
5MG 119 In Stock
10MG 181 In Stock
25MG 297 In Stock
50MG 410 In Stock
100MG 554 In Stock
200MG 736 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Galnon TFA
  • Note
    Research use only, not for human use.
  • Brief Description
    Galnon is a novel non-peptide galanin receptor agonist (GAL1 and GAL2 with Ki of 11.7 and 34.1 μM respectively).
  • Description
    Galnon TFA is a selective and non-peptide agonist of galanin GAL1 and GAL2 receptor, with Kis of 11.7 and 34.1 μM respectively. Galnon TFA exhibits anticonvulsant and anxiolytic effects.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Neuropeptide Y Receptor
  • Recptor
    Neuropeptide Y Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1217448-19-5
  • Formula Weight
    792.84
  • Molecular Formula
    C42H47F3N4O8
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 125 mg/mL (157.66 mM; Ultrasonic )
  • SMILES
    C(C(O)=O)(F)(F)F.C(OC(N[C@@H](CC1CCCCC1)C(N[C@H](C(NC=2C=C3C(=CC2)C(C)=CC(=O)O3)=O)CCCCN)=O)=O)C4C=5C(C=6C4=CC=CC6)=CC=CC5
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Bartfai T, et, al. Galmic, a nonpeptide galanin receptor agonist, affects behaviors in seizure, pain, and forced-swim tests. Proc Natl Acad Sci U S A. 2004 Jul 13;101(28):10470-5.?
molnova catalog
related products
  • Galnon

    Galnon is a galanin receptor agonist, improves intrinsic cortical bone tissue propertiesGalnon has been characterized to inhibit seizures, decrease feeding behaviour, diminish physical signs of opiate withdrawal and to alleviate heat-hyperalgesic response to partial sciatic nerve injury.

  • Selvigaltin

    Selvigaltin (GB1211) is a Gal-3 inhibitor with potential anticancer activity. Selvigaltin is used in the study of cirrhosis and cancer.

  • CART (55-102) (rat)

    Cocaine- and amphetamine-regulated transcript (CART) with potent appetite-suppressing activity. Satiety factor; inhibits normal and starvation-induced feeding. Closely related to the actions of leptin and neuropeptide Y; blocks the neuropeptide Y-induced feeding response. Induces anxiety and stress behavior in rodents.